Accidental children poisoning with methadone: an Iranian pediatric sectional study

Sayena Jabbehdari1, Fariba Farnaghi2, Seyed Fakhreddin Shariatmadari1

  • 1Pediatric Neurology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Methadone poisoning in children is a significant concern in Iran. Prolonged naloxone treatment is recommended due to potential symptom recurrence and complications like apnea and pneumonia.

Area of Science:

  • Pediatric Toxicology
  • Clinical Toxicology

Background:

  • Methadone poisoning is a common issue among children in Iran.
  • Recent years have seen a changing pattern and increase in methadone toxicity cases.

Purpose of the Study:

  • To assess the clinical characteristics and outcomes of methadone poisoning in children under 12.
  • To identify key findings and inform treatment strategies for pediatric methadone toxicity.

Main Methods:

  • A descriptive-sectional study was conducted on children under 12 admitted with methadone poisoning.
  • Clinical symptoms, paraclinical findings, and treatment interventions were evaluated.

Main Results:

  • Drowsiness, miotic pupils, vomiting, rapid shallow breathing, and apnea were common clinical findings.
  • Respiratory acidosis, leukocytosis, and QT interval prolongation were observed in paraclinical tests.
  • Apnea was associated with longer treatment duration and increased risk of aspiration pneumonia.

Conclusions:

  • Extended treatment with naloxone is suggested for pediatric methadone poisoning.
  • The possibility of symptom recurrence after methadone discontinuation should be considered.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
279
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
229
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229